The Allen Institute, University of Washington, and Fred Hutch Cancer Center are launching a $95 million effort to use AI to design biology that doesn’t exist in nature. Called AI BioDesign and led scientifically by Nobel laureate David Baker and genome scientist Jay Shendure, the initiative will use AI models to propose new DNA sequences and biological molecules.

Three of Seattle’s top scientific institutions are launching a nearly $95 million research initiative that will generate data and train AI models to design proteins and genes that don’t exist in nature — sharing the results freely to help others develop new medicines and materials.

A nearly $95 million Seattle research effort aims to use artificial intelligence to design biological molecules that don't exist in nature.

Researchers set out on a bold new initiative to learn life’s instructions and begin designing new biological functions.

The institute has launched the Brain Health Accelerator, an international collaboration involving about 30 research organizations that will use artificial intelligence, human brain tissue and advanced cellular mapping to better understand diseases including Parkinson’s, Alzheimer’s disease, ALS, Huntington’s disease and Lewy body dementia.

When Lionel Messi and fellow stars of the FIFA World Cup enter "the zone," what's happening in their brains? Today, neuroscientist Dr. Rui Costa tells Sanjay how you can think like a top athlete and find your own "flow state."

A Seattle-based nonprofit is launching an initiative to translate its knowledge into drug development for neurodegenerative diseases, including Alzheimer’s.

The Allen Institute launched a new project to accelerate the mechanistic understanding of neurodegenerative diseases and develop potential therapies.

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.